Clinical Trials Sponsored by Dr. Falk Pharma GmbH
Total 54 results
-
Dr. Falk Pharma GmbHRecruiting
-
Dr. Falk Pharma GmbHRecruiting
-
Dr. Falk Pharma GmbHCompleted
-
Dr. Falk Pharma GmbHCompletedIncomplete Microscopic ColitisGermany, Sweden
-
Dr. Falk Pharma GmbHTerminatedPrimary Biliary CirrhosisFrance, Germany
-
Dr. Falk Pharma GmbHCompleted
-
Dr. Falk Pharma GmbHCompleted
-
Dr. Falk Pharma GmbHTerminatedRadiation ProctitisGermany
-
Dr. Falk Pharma GmbHRecruiting
-
Dr. Falk Pharma GmbHCompleted
-
Dr. Falk Pharma GmbHCompletedPrimary Biliary CirrhosisGermany
-
Dr. Falk Pharma GmbHCompleted
-
Dr. Falk Pharma GmbHCompletedUncomplicated DiverticulitisGermany
-
Dr. Falk Pharma GmbHTerminatedDiverticulitisGermany
-
Dr. Falk Pharma GmbHTerminatedUlcerative ColitisGermany
-
Dr. Falk Pharma GmbHCompletedPrimary Sclerosing CholangitisAustria, Germany, Norway
-
Dr. Falk Pharma GmbHCompletedOral Chronic Graft vs Host DiseaseGermany, Israel
-
Dr. Falk Pharma GmbHCompletedEosinophilic EsophagitisGermany
-
Dr. Falk Pharma GmbHCompleted
-
Dr. Falk Pharma GmbHCompleted
-
Dr. Falk Pharma GmbHCompletedCollagenous ColitisGermany
-
Dr. Falk Pharma GmbHCompletedColitis, UlcerativeGermany
-
Dr. Falk Pharma GmbHCompletedPreventing Postoperative Relapse in Crohn's Disease Patients at Risk: Azathioprine Versus MesalazineCrohn's DiseaseAustria, Germany
-
Dr. Falk Pharma GmbHCompletedRecurrence | Colitis, UlcerativeGermany
-
Dr. Falk Pharma GmbHRecruiting
-
Dr. Falk Pharma GmbHCompletedEosinophilic EsophagitisGermany
-
Dr. Falk Pharma GmbHCompletedTraveler's DiarrheaEcuador, Guatemala, India
-
Dr. Falk Pharma GmbHCompleted
-
Dr. Falk Pharma GmbHCompleted
-
Dr. Falk Pharma GmbHTerminatedDiverticulitisUnited States
-
Dr. Falk Pharma GmbHCompletedEosinophilic EsophagitisGermany
-
Dr. Falk Pharma GmbHCompletedActive Ulcerative ColitisGermany
-
Dr. Falk Pharma GmbHCompletedColonic DiverticulosisGermany
-
Dr. Falk Pharma GmbHCompleted
-
Dr. Falk Pharma GmbHCompletedCrohn´s DiseaseGermany
-
Rafa LaboratoriesDr. Falk Pharma GmbHCompleted
-
Technische Universität DresdenDr. Falk Pharma GmbHCompleted
-
Technische Universität DresdenDr. Falk Pharma GmbHCompletedLeukemia | Graft-Versus-Host DiseaseGermany
-
Sublimity Therapeutics Holdco LimitedDr. Falk Pharma GmbHTerminatedColitis, UlcerativeUnited States, United Kingdom, Serbia, Canada, Russian Federation, Poland, Israel, Romania, Ireland, Spain, Hungary, Ukraine, Belarus, Italy, Bulgaria, France, Germany
-
Russian Academy of Medical SciencesDr. Falk Pharma GmbHCompletedGastroesophageal Reflux DiseaseRussian Federation
-
National Heart and Lung InstituteDr. Falk Pharma GmbHUnknown
-
Dr. Falk Pharma GmbHThe Swedish Organization for Studies on Inflammatory Bowel DiseaseCompletedInduction and Maintaining Remission of Collagenous ColitisGermany, Sweden
-
University Hospital TuebingenDr. Falk Pharma GmbH; Principal Investigator: Univ. Hosp. Tuebingen, Dept....Completed
-
Prof. Dr. Wolfgang WickEssex Pharma GmbHCompletedGlioblastomaGermany, Austria, Switzerland
-
Dr. Claudia BösmüllerAstellas Pharma GmbHCompletedKidney TransplantationAustria
-
Dr. Claudia BösmüllerAstellas Pharma GmbHCompletedPancreas-Kidney TransplantationAustria
-
UMC UtrechtZonMw: The Netherlands Organisation for Health Research and Development; Dr... and other collaboratorsCompleted
-
Hospital Universitario Dr. Jose E. GonzalezEver Neuro Pharma GmbHRecruitingDiabetes Mellitus, Type 2 | Ischemic Stroke, Acute | Blood Brain BarrierMexico
-
Ever Neuro Pharma GmbHIDV Data analysis and study planning Dr. RahlfsRecruitingAcute Ischemic StrokeAustria
-
Dr. August Wolff GmbH & Co. KG ArzneimittelPharmaxi LLC; Labor Dr. Fenner und KollegenRecruitingUpper Respiratory Infection | Sore-throatUkraine